For Institutional Investors in the US

Global Perspectives

Equity Perspectives

Quarterly insight from our equity teams to help clients navigate the markets and opportunities ahead.

Global Dividend Index

The first of its kind, quarterly, long-term study into global dividend trends.

Fixed Income Perspectives

Quarterly insight from our fixed income teams to help clients navigate the markets and opportunities ahead.

Decarbonisation in EM Index

Perspectives and insights on Mexico, Central America and the Caribbean, and South America.

Alternative Perspectives

Insight from our alternatives team to help clients navigate the markets and opportunities ahead.

Sovereign Debt Index

A long-term study into trends in government indebtedness, with the investment opportunities and risks it presents.

LATEST INSIGHTS

Subscribe for relevant insights delivered straight to your inbox

Equity Income Investing: Key Market Drivers

Equity Income Investing: Key Market Drivers

Key market drivers from the first quarter and key themes to watch going forward.

The Fog of War: A Multi-Asset View

The Fog of War: A Multi-Asset View

The prospects for financial markets as investors contend with market uncertainty around central bank hawkishness, the war in Ukraine and lingering Chinese concerns.

Global Stocks Provide Clues to Accelerating Inflation

Global Stocks Provide Clues to Accelerating Inflation

Equity market signals and economic data indicate U.S. consumers are tolerating higher energy prices – for now.

One Down, Three to Go
Quick Views Volatility

One Down, Three to Go

Updated strategist predictions for 2022 and a look at the relationship between first quarter and rest of year returns.

How do ESG factors impact valuations within the technology sector?

How do ESG factors impact valuations within the technology sector?

Key findings from a study exploring the relationship between environmental, social and governance (ESG) factors and tech company valuations.

Can Biotech Bounce Back?

Can Biotech Bounce Back?

For more than a year, biotechnology stocks have been deep in the red, even as medical breakthroughs continue – a disconnect we think is unlikely to last.

An Investor’s China Conundrum

An Investor’s China Conundrum

While we believe the opportunity remains promising, equity investors must understand the growing role political governance plays in China’s economy.

SEC Unveils Long-Awaited Climate-Related Disclosure Recommendations

SEC Unveils Long-Awaited Climate-Related Disclosure Recommendations

The SEC has proposed new climate-related disclosures for public companies. What are the details?

2022: Optimal Conditions for a Liquid Alternative Toolset?
Quick Views Volatility

2022: Optimal Conditions for a Liquid Alternative Toolset?

Considering a multi-strategy approach to using liquid alternatives to help improve diversification.

The Domino Effect: Russia, Ukraine and the Rest of EM

The Domino Effect: Russia, Ukraine and the Rest of EM

The domino effect of rising prices from the disrupted supply of commodities and resources from Russia and Ukraine could have far-reaching effects across EMs.

Keep Calm and (Commodity) Carry On

Keep Calm and (Commodity) Carry On

Geopolitical tensions and an outbreak of inflationary expectations have flowed into a less sanguine environment for all asset classes, including commodities.